Association of Parvovirus B19 Infection with Systemic Lupus Erythematosus: Role of Th1 Predominance

REFERENCES

1. 1.↵
   1. Hession MT,
   2. Au SC,
   3. Gottlieb AB

   . Parvovirus B19-associated systemic lupus erythematosus: clinical mimicry or autoimmune induction? J Rheumatol 2010;37:2430–2.

   OpenUrlFREE Full Text
2. 2.↵
   1. Isa A,
   2. Lundqvist A,
   3. Lindblom A,
   4. Tolfvenstam T,
   5. Broliden K

   . Cytokine responses in acute and persistent human parvovirus B19 infection. Clin Exp Immunol 2007;147:419–25.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Tokano Y,
   2. Morimoto S,
   3. Kaneko H,
   4. Amano H,
   5. Nozawa K,
   6. Takasaki Y,
   7. et al.

   Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE) — relation to Th1- and Th2-derived cytokines. Clin Exp Immunol 1999;116:169–73.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Aringer M,
   2. Stummvoll GH,
   3. Steiner G,
   4. Köller M,
   5. Steiner CW,
   6. Höfler E,
   7. et al.

   Serum interleukin-15 is elevated in systemic lupus erythematosus. Rheumatology 2001;40:876–81.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Segal R,
   2. Dayan M,
   3. Zinger H,
   4. Habut B,
   5. Shearer GM,
   6. Mozes E

   . The effect of IL-12 on clinical and laboratory aspects of experimental SLE in young and aging mice. Exp Gerontol 2003;38:661–8.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Bo H,
   2. Wei XQ,
   3. Dong H,
   4. Zhang Y,
   5. Lv P,
   6. Liu W,
   7. et al.

   Elevated expression of transmembrane IL-15 in immune cells correlates with the development of murine lupus: a potential target for immunotherapy against SLE. Scand J Immunol 2009;69:119–29.

   OpenUrlCrossRefPubMed